HEADER TRANSFERASE 29-OCT-18 6MWE TITLE CRYSTAL STRUCTURE OF TIE2 IN COMPLEX WITH DECIPERA COMPOUND DP1919 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOPOIETIN-1 RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENDOTHELIAL TYROSINE KINASE,TUNICA INTERNA ENDOTHELIAL CELL COMPND 5 KINASE,TYROSINE KINASE WITH IG AND EGF HOMOLOGY DOMAINS-2,TYROSINE- COMPND 6 PROTEIN KINASE RECEPTOR TEK,TYROSINE-PROTEIN KINASE RECEPTOR TIE-2, COMPND 7 HTIE2,P140 TEK; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TEK, TIE2, VMCM, VMCM1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPTERA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 30263; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: VCID 2501 KEYWDS TIE2, DP1919, EMERALDBIO, DECIPHERA, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.CHUN,J.ABENDROTH,T.E.EDWARDS REVDAT 2 11-OCT-23 6MWE 1 REMARK REVDAT 1 21-NOV-18 6MWE 0 JRNL AUTH A.S.HARNEY,G.S.KARAGIANNIS,J.PIGNATELLI,B.D.SMITH, JRNL AUTH 2 E.KADIOGLU,S.C.WISE,M.M.HOOD,M.D.KAUFMAN,C.B.LEARY,W.P.LU, JRNL AUTH 3 G.AL-ANI,X.CHEN,D.ENTENBERG,M.H.OKTAY,Y.WANG,L.CHUN, JRNL AUTH 4 M.DE PALMA,J.G.JONES,D.L.FLYNN,J.S.CONDEELIS JRNL TITL THE SELECTIVE TIE2 INHIBITOR REBASTINIB BLOCKS RECRUITMENT JRNL TITL 2 AND FUNCTION OF TIE2 JRNL REF MOL. CANCER THER. V. 16 2486 2017 JRNL REFN ESSN 1538-8514 JRNL PMID 28838996 JRNL DOI 10.1158/1535-7163.MCT-17-0241 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.12 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 44082 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.149 REMARK 3 R VALUE (WORKING SET) : 0.148 REMARK 3 FREE R VALUE : 0.166 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2173 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.10 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3081 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.75 REMARK 3 BIN R VALUE (WORKING SET) : 0.1780 REMARK 3 BIN FREE R VALUE SET COUNT : 154 REMARK 3 BIN FREE R VALUE : 0.2170 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4420 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 102 REMARK 3 SOLVENT ATOMS : 231 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.11 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.90000 REMARK 3 B22 (A**2) : -1.90000 REMARK 3 B33 (A**2) : 3.80000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.030 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.025 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.068 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.501 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.959 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4643 ; 0.014 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4237 ; 0.005 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6330 ; 1.335 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9655 ; 0.956 ; 2.983 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 584 ; 6.379 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 194 ;34.919 ;23.660 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 699 ;13.605 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 27 ;16.585 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 702 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5309 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1064 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : NULL 0 NULL 0 REMARK 3 ORIGIN FOR THE GROUP (A): -6.314 45.240 117.417 REMARK 3 T TENSOR REMARK 3 T11: 0.0629 T22: 0.2133 REMARK 3 T33: 0.0161 T12: -0.0725 REMARK 3 T13: -0.0293 T23: 0.0453 REMARK 3 L TENSOR REMARK 3 L11: 1.1639 L22: 1.1223 REMARK 3 L33: 1.4846 L12: -0.3455 REMARK 3 L13: 0.5082 L23: -0.2568 REMARK 3 S TENSOR REMARK 3 S11: -0.0817 S12: 0.0054 S13: -0.0041 REMARK 3 S21: 0.0276 S22: 0.1350 S23: 0.0141 REMARK 3 S31: 0.0932 S32: -0.1580 S33: -0.0533 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 0 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 ORIGIN FOR THE GROUP (A): 14.700 25.487 142.628 REMARK 3 T TENSOR REMARK 3 T11: 0.1771 T22: 0.0453 REMARK 3 T33: 0.0205 T12: -0.0003 REMARK 3 T13: -0.0298 T23: -0.0103 REMARK 3 L TENSOR REMARK 3 L11: 0.8952 L22: 0.8582 REMARK 3 L33: 2.1141 L12: -0.2660 REMARK 3 L13: 0.4634 L23: -0.1044 REMARK 3 S TENSOR REMARK 3 S11: -0.0552 S12: 0.0306 S13: 0.0259 REMARK 3 S21: 0.0393 S22: 0.0014 S23: 0.0839 REMARK 3 S31: -0.1674 S32: -0.0046 S33: 0.0538 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 6MWE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1000237726. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JAN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9774 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44133 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 45.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.183 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.4300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.31 REMARK 200 R MERGE FOR SHELL (I) : 0.47800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.810 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2OO8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: JCSG+ SCREEN E4: 1.26M AMMONIUM REMARK 280 SULPHATE: 200MM LITHIUM SULPHATE, 100MM TRIS PH 8.5: CRYO: 25% REMARK 280 EG IN 3 STEPS, PH 4.6, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.72500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 44.36250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 133.08750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 808 REMARK 465 ASN A 809 REMARK 465 ASN A 810 REMARK 465 PRO A 811 REMARK 465 ASP A 812 REMARK 465 PRO A 813 REMARK 465 THR A 814 REMARK 465 ILE A 815 REMARK 465 LYS A 858 REMARK 465 GLU A 859 REMARK 465 TYR A 860 REMARK 465 ALA A 861 REMARK 465 SER A 862 REMARK 465 LYS A 863 REMARK 465 ASP A 864 REMARK 465 ASP A 865 REMARK 465 HIS A 866 REMARK 465 ARG A 867 REMARK 465 ASP A 868 REMARK 465 PHE A 869 REMARK 465 ALA A 870 REMARK 465 VAL A 993 REMARK 465 LYS A 994 REMARK 465 ALA A 1123 REMARK 465 ALA A 1124 REMARK 465 LYS B 808 REMARK 465 ASN B 809 REMARK 465 ASN B 810 REMARK 465 PRO B 811 REMARK 465 ASP B 812 REMARK 465 PRO B 813 REMARK 465 THR B 814 REMARK 465 ILE B 815 REMARK 465 MET B 857 REMARK 465 LYS B 858 REMARK 465 GLU B 859 REMARK 465 TYR B 860 REMARK 465 ALA B 861 REMARK 465 SER B 862 REMARK 465 LYS B 863 REMARK 465 ASP B 864 REMARK 465 ASP B 865 REMARK 465 HIS B 866 REMARK 465 ARG B 867 REMARK 465 ASP B 868 REMARK 465 PHE B 869 REMARK 465 ALA B 870 REMARK 465 TYR B 992 REMARK 465 VAL B 993 REMARK 465 LYS B 994 REMARK 465 ALA B 1123 REMARK 465 ALA B 1124 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 816 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASN A 822 CG OD1 ND2 REMARK 470 ASP A 823 CG OD1 OD2 REMARK 470 LYS A 825 CG CD CE NZ REMARK 470 GLU A 832 CG CD OE1 OE2 REMARK 470 ASN A 834 CG OD1 ND2 REMARK 470 PHE A 835 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 844 CG CD CE NZ REMARK 470 ASP A 846 CG OD1 OD2 REMARK 470 LEU A 848 CG CD1 CD2 REMARK 470 ARG A 849 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 874 CG CD OE1 OE2 REMARK 470 LYS A 878 CG CD CE NZ REMARK 470 GLU A 893 CG CD OE1 OE2 REMARK 470 ARG A 895 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 916 CG CD CE NZ REMARK 470 GLU A 974 CG CD OE1 OE2 REMARK 470 TYR A 992 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 995 CG CD CE NZ REMARK 470 MET A 997 CG SD CE REMARK 470 GLU A1058 CG CD OE1 OE2 REMARK 470 LEU A1061 CG CD1 CD2 REMARK 470 ARG A1099 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1110 CG CD CE NZ REMARK 470 GLU A1122 CG CD OE1 OE2 REMARK 470 TYR B 816 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 VAL B 818 CG1 CG2 REMARK 470 LEU B 819 CG CD1 CD2 REMARK 470 ASP B 820 CG OD1 OD2 REMARK 470 ASN B 822 CG OD1 ND2 REMARK 470 ASP B 823 CG OD1 OD2 REMARK 470 LYS B 825 CG CD CE NZ REMARK 470 GLU B 832 CG CD OE1 OE2 REMARK 470 ASN B 834 CG OD1 ND2 REMARK 470 PHE B 835 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN B 837 CG CD OE1 NE2 REMARK 470 LYS B 844 CG CD CE NZ REMARK 470 LYS B 845 CG CD CE NZ REMARK 470 ASP B 846 CG OD1 OD2 REMARK 470 LEU B 848 CG CD1 CD2 REMARK 470 ARG B 849 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 856 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 874 CG CD OE1 OE2 REMARK 470 LYS B 878 CG CD CE NZ REMARK 470 GLU B 893 CG CD OE1 OE2 REMARK 470 HIS B 894 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 895 CG CD NE CZ NH1 NH2 REMARK 470 TYR B 897 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LEU B 898 CG CD1 CD2 REMARK 470 GLU B 974 CG CD OE1 OE2 REMARK 470 VAL B 991 CG1 CG2 REMARK 470 LYS B 995 CG CD CE NZ REMARK 470 THR B 996 OG1 CG2 REMARK 470 MET B 997 CG SD CE REMARK 470 ARG B 999 CG CD NE CZ NH1 NH2 REMARK 470 LEU B1061 CG CD1 CD2 REMARK 470 ARG B1094 CG CD NE CZ NH1 NH2 REMARK 470 GLU B1097 CG CD OE1 OE2 REMARK 470 ARG B1099 CG CD NE CZ NH1 NH2 REMARK 470 LYS B1110 CG CD CE NZ REMARK 470 GLU B1122 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 955 CA - CB - CG ANGL. DEV. = 14.9 DEGREES REMARK 500 ASP B1020 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 827 -135.05 -125.61 REMARK 500 ASP A 846 -112.45 46.47 REMARK 500 ARG A 895 -128.78 51.64 REMARK 500 ASP A 923 73.32 -152.68 REMARK 500 ARG A 963 -10.36 81.44 REMARK 500 ASP A 964 50.28 -148.17 REMARK 500 GLN B 827 -134.69 -126.19 REMARK 500 ASP B 846 -111.56 48.08 REMARK 500 HIS B 894 -82.87 -114.58 REMARK 500 ARG B 895 -123.71 -97.40 REMARK 500 ASP B 923 76.69 -155.28 REMARK 500 ARG B 963 -11.84 79.52 REMARK 500 ASP B 964 50.05 -148.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 919 A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 919 B 1203 DBREF 6MWE A 808 1124 UNP Q02763 TIE2_HUMAN 808 1124 DBREF 6MWE B 808 1124 UNP Q02763 TIE2_HUMAN 808 1124 SEQRES 1 A 317 LYS ASN ASN PRO ASP PRO THR ILE TYR PRO VAL LEU ASP SEQRES 2 A 317 TRP ASN ASP ILE LYS PHE GLN ASP VAL ILE GLY GLU GLY SEQRES 3 A 317 ASN PHE GLY GLN VAL LEU LYS ALA ARG ILE LYS LYS ASP SEQRES 4 A 317 GLY LEU ARG MET ASP ALA ALA ILE LYS ARG MET LYS GLU SEQRES 5 A 317 TYR ALA SER LYS ASP ASP HIS ARG ASP PHE ALA GLY GLU SEQRES 6 A 317 LEU GLU VAL LEU CYS LYS LEU GLY HIS HIS PRO ASN ILE SEQRES 7 A 317 ILE ASN LEU LEU GLY ALA CYS GLU HIS ARG GLY TYR LEU SEQRES 8 A 317 TYR LEU ALA ILE GLU TYR ALA PRO HIS GLY ASN LEU LEU SEQRES 9 A 317 ASP PHE LEU ARG LYS SER ARG VAL LEU GLU THR ASP PRO SEQRES 10 A 317 ALA PHE ALA ILE ALA ASN SER THR ALA SER THR LEU SER SEQRES 11 A 317 SER GLN GLN LEU LEU HIS PHE ALA ALA ASP VAL ALA ARG SEQRES 12 A 317 GLY MET ASP TYR LEU SER GLN LYS GLN PHE ILE HIS ARG SEQRES 13 A 317 ASP LEU ALA ALA ARG ASN ILE LEU VAL GLY GLU ASN TYR SEQRES 14 A 317 VAL ALA LYS ILE ALA ASP PHE GLY LEU SER ARG GLY GLN SEQRES 15 A 317 GLU VAL TYR VAL LYS LYS THR MET GLY ARG LEU PRO VAL SEQRES 16 A 317 ARG TRP MET ALA ILE GLU SER LEU ASN TYR SER VAL TYR SEQRES 17 A 317 THR THR ASN SER ASP VAL TRP SER TYR GLY VAL LEU LEU SEQRES 18 A 317 TRP GLU ILE VAL SER LEU GLY GLY THR PRO TYR CYS GLY SEQRES 19 A 317 MET THR CYS ALA GLU LEU TYR GLU LYS LEU PRO GLN GLY SEQRES 20 A 317 TYR ARG LEU GLU LYS PRO LEU ASN CYS ASP ASP GLU VAL SEQRES 21 A 317 TYR ASP LEU MET ARG GLN CYS TRP ARG GLU LYS PRO TYR SEQRES 22 A 317 GLU ARG PRO SER PHE ALA GLN ILE LEU VAL SER LEU ASN SEQRES 23 A 317 ARG MET LEU GLU GLU ARG LYS THR TYR VAL ASN THR THR SEQRES 24 A 317 LEU TYR GLU LYS PHE THR TYR ALA GLY ILE ASP CYS SER SEQRES 25 A 317 ALA GLU GLU ALA ALA SEQRES 1 B 317 LYS ASN ASN PRO ASP PRO THR ILE TYR PRO VAL LEU ASP SEQRES 2 B 317 TRP ASN ASP ILE LYS PHE GLN ASP VAL ILE GLY GLU GLY SEQRES 3 B 317 ASN PHE GLY GLN VAL LEU LYS ALA ARG ILE LYS LYS ASP SEQRES 4 B 317 GLY LEU ARG MET ASP ALA ALA ILE LYS ARG MET LYS GLU SEQRES 5 B 317 TYR ALA SER LYS ASP ASP HIS ARG ASP PHE ALA GLY GLU SEQRES 6 B 317 LEU GLU VAL LEU CYS LYS LEU GLY HIS HIS PRO ASN ILE SEQRES 7 B 317 ILE ASN LEU LEU GLY ALA CYS GLU HIS ARG GLY TYR LEU SEQRES 8 B 317 TYR LEU ALA ILE GLU TYR ALA PRO HIS GLY ASN LEU LEU SEQRES 9 B 317 ASP PHE LEU ARG LYS SER ARG VAL LEU GLU THR ASP PRO SEQRES 10 B 317 ALA PHE ALA ILE ALA ASN SER THR ALA SER THR LEU SER SEQRES 11 B 317 SER GLN GLN LEU LEU HIS PHE ALA ALA ASP VAL ALA ARG SEQRES 12 B 317 GLY MET ASP TYR LEU SER GLN LYS GLN PHE ILE HIS ARG SEQRES 13 B 317 ASP LEU ALA ALA ARG ASN ILE LEU VAL GLY GLU ASN TYR SEQRES 14 B 317 VAL ALA LYS ILE ALA ASP PHE GLY LEU SER ARG GLY GLN SEQRES 15 B 317 GLU VAL TYR VAL LYS LYS THR MET GLY ARG LEU PRO VAL SEQRES 16 B 317 ARG TRP MET ALA ILE GLU SER LEU ASN TYR SER VAL TYR SEQRES 17 B 317 THR THR ASN SER ASP VAL TRP SER TYR GLY VAL LEU LEU SEQRES 18 B 317 TRP GLU ILE VAL SER LEU GLY GLY THR PRO TYR CYS GLY SEQRES 19 B 317 MET THR CYS ALA GLU LEU TYR GLU LYS LEU PRO GLN GLY SEQRES 20 B 317 TYR ARG LEU GLU LYS PRO LEU ASN CYS ASP ASP GLU VAL SEQRES 21 B 317 TYR ASP LEU MET ARG GLN CYS TRP ARG GLU LYS PRO TYR SEQRES 22 B 317 GLU ARG PRO SER PHE ALA GLN ILE LEU VAL SER LEU ASN SEQRES 23 B 317 ARG MET LEU GLU GLU ARG LYS THR TYR VAL ASN THR THR SEQRES 24 B 317 LEU TYR GLU LYS PHE THR TYR ALA GLY ILE ASP CYS SER SEQRES 25 B 317 ALA GLU GLU ALA ALA HET SO4 A1201 5 HET SO4 A1202 5 HET 919 A1203 41 HET SO4 B1201 5 HET SO4 B1202 5 HET 919 B1203 41 HETNAM SO4 SULFATE ION HETNAM 919 4-[4-({[3-TERT-BUTYL-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5- HETNAM 2 919 YL]CARBAMOYL}AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE- HETNAM 3 919 2-CARBOXAMIDE HETSYN 919 DCC-2036 FORMUL 3 SO4 4(O4 S 2-) FORMUL 5 919 2(C30 H28 F N7 O3) FORMUL 9 HOH *231(H2 O) HELIX 1 AA1 ASP A 820 ASN A 822 5 3 HELIX 2 AA2 GLU A 872 GLY A 880 1 9 HELIX 3 AA3 ASN A 909 SER A 917 1 9 HELIX 4 AA4 ARG A 918 ASP A 923 1 6 HELIX 5 AA5 ASP A 923 ASN A 930 1 8 HELIX 6 AA6 SER A 937 LYS A 958 1 22 HELIX 7 AA7 ALA A 966 ARG A 968 5 3 HELIX 8 AA8 GLU A 974 TYR A 976 5 3 HELIX 9 AA9 GLY A 984 GLY A 988 5 5 HELIX 10 AB1 ARG A 999 MET A 1005 5 7 HELIX 11 AB2 ALA A 1006 SER A 1013 1 8 HELIX 12 AB3 THR A 1016 SER A 1033 1 18 HELIX 13 AB4 THR A 1043 LEU A 1051 1 9 HELIX 14 AB5 PRO A 1052 GLY A 1054 5 3 HELIX 15 AB6 ASP A 1064 TRP A 1075 1 12 HELIX 16 AB7 LYS A 1078 ARG A 1082 5 5 HELIX 17 AB8 SER A 1084 GLU A 1098 1 15 HELIX 18 AB9 ASP A 1117 GLU A 1121 5 5 HELIX 19 AC1 ASP B 820 ASN B 822 5 3 HELIX 20 AC2 GLU B 872 GLY B 880 1 9 HELIX 21 AC3 ASN B 909 SER B 917 1 9 HELIX 22 AC4 ARG B 918 ASP B 923 1 6 HELIX 23 AC5 ASP B 923 ASN B 930 1 8 HELIX 24 AC6 SER B 937 LYS B 958 1 22 HELIX 25 AC7 ALA B 966 ARG B 968 5 3 HELIX 26 AC8 GLU B 974 TYR B 976 5 3 HELIX 27 AC9 GLY B 984 GLY B 988 5 5 HELIX 28 AD1 ARG B 999 MET B 1005 5 7 HELIX 29 AD2 ALA B 1006 SER B 1013 1 8 HELIX 30 AD3 THR B 1016 SER B 1033 1 18 HELIX 31 AD4 THR B 1043 LEU B 1051 1 9 HELIX 32 AD5 PRO B 1052 GLY B 1054 5 3 HELIX 33 AD6 ASP B 1064 TRP B 1075 1 12 HELIX 34 AD7 LYS B 1078 ARG B 1082 5 5 HELIX 35 AD8 SER B 1084 GLU B 1098 1 15 HELIX 36 AD9 ASP B 1117 GLU B 1121 5 5 SHEET 1 AA1 5 ILE A 824 GLY A 833 0 SHEET 2 AA1 5 GLY A 836 LYS A 845 -1 O LYS A 840 N ASP A 828 SHEET 3 AA1 5 LEU A 848 MET A 857 -1 O ILE A 854 N LEU A 839 SHEET 4 AA1 5 TYR A 897 GLU A 903 -1 O ILE A 902 N ALA A 853 SHEET 5 AA1 5 LEU A 888 HIS A 894 -1 N CYS A 892 O TYR A 899 SHEET 1 AA2 2 ILE A 970 VAL A 972 0 SHEET 2 AA2 2 ALA A 978 ILE A 980 -1 O LYS A 979 N LEU A 971 SHEET 1 AA3 5 ILE B 824 GLY B 833 0 SHEET 2 AA3 5 GLY B 836 LYS B 845 -1 O LYS B 840 N ASP B 828 SHEET 3 AA3 5 LEU B 848 LYS B 855 -1 O MET B 850 N ILE B 843 SHEET 4 AA3 5 LEU B 898 GLU B 903 -1 O ILE B 902 N ALA B 853 SHEET 5 AA3 5 LEU B 888 GLU B 893 -1 N CYS B 892 O TYR B 899 SHEET 1 AA4 2 ILE B 970 VAL B 972 0 SHEET 2 AA4 2 ALA B 978 ILE B 980 -1 O LYS B 979 N LEU B 971 SITE 1 AC1 7 ARG A 999 CYS A1044 ALA A1045 HOH A1302 SITE 2 AC1 7 HIS B 881 TYR B 954 LYS B 958 SITE 1 AC2 2 GLN A 939 HIS A 943 SITE 1 AC3 19 ILE A 830 ALA A 853 LYS A 855 GLU A 872 SITE 2 AC3 19 VAL A 875 LEU A 876 ILE A 885 ILE A 886 SITE 3 AC3 19 GLU A 903 ALA A 905 GLY A 908 ALA A 981 SITE 4 AC3 19 ASP A 982 PHE A 983 GLY A 984 ARG A 987 SITE 5 AC3 19 GLN A 989 HOH A1376 HOH A1401 SITE 1 AC4 4 TYR A1015 HOH A1325 ARG B 950 ASN B1093 SITE 1 AC5 2 GLN B 939 HIS B 943 SITE 1 AC6 20 ILE B 830 ALA B 853 LYS B 855 GLU B 872 SITE 2 AC6 20 LEU B 876 ILE B 885 ILE B 886 ILE B 902 SITE 3 AC6 20 GLU B 903 TYR B 904 ALA B 905 PHE B 960 SITE 4 AC6 20 ILE B 980 ALA B 981 ASP B 982 PHE B 983 SITE 5 AC6 20 GLY B 984 ARG B 987 GLN B 989 HOH B1383 CRYST1 63.810 63.810 177.450 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015672 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015672 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005635 0.00000